[1] Sauvage FJ, Philip EH, Spencer SD, et al. Stimulation of megakaryocytopoiesis by the c-mpl ligand[J]. Nature, 1994;369: 533-538. [2] Lok S, Kaushansky K, Holly RD, et al. Cloning and expression of marine thrombopoietin cDNA and stimulation of platelet production in vivo[J]. Nature, 1994;69: 565-571. [3] Kaushansky K. Thrombopoietin[J]. N Eng J Med, 1998;10: 746-754. [4] Solar GP, Kerr WG, Zeigler FC. Role of c-mpl in early hematopoietis[J]. Blood, 1998;92: 4-10. [5] Itoh R, Katayama N, Kato T. Activity of the ligand for c-mpl, thrombopoietin, in Early hemapoiesis[J]. Brit J Hematol, 1996;94: 228-235. [6] Avanzi GC, Lista P, Giovinazzo B, et al. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features[J]. Br J Haematol, 1988;69: 359-366. [7] Broxmeyer HE, Cooper S, Hague N, et al. Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice[J]. Ann Hematol, 1995;71: 235-246. [8] Hendrie PC, Miyazawa K, Yang YC, et al. Mast cell growth factor (c-kit ligand) enhances cytokine stimulation of the human factor dependent cell line, MO7e[J]. Exp Hematol, 1991;19: 1031-1037. [9] Berkow RL, Straneva JE, Bruno E, et al. Isolation of human megakaryocytes by density centrifugation and counter flow centrifugal elutriation[J]. J Lab Clin Med, 1984;103: 811-818. [10] Tortolani PJ, Johnston JA, Bacon CM, et al. Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK2[J]. Blood, 1995;85: 3444-3451. [11] Neelis K, Lou QL, Thomas G. Prevention of thrombocytopenia by thrombopoietin in myelosuppressed rhesus monkeys accompanied by prominent erythropoietin stimulation and iron depletion[J]. Blood, 1997;90: 58-63. [12] 罗庆良, Neelis KJ, Wagemaker G. 重组人血小板生长因子和重组人粒细胞集落刺激因子对急性放射病猴的作用[J]. 中华放射医学与防护杂志, 1999;19: 34-38. [13] 罗庆良. 血小板生成素对猴急性放射病的治疗[J]. 实验血液学杂志, 1996;4: 324-328. [14] Brandt JE, Bahlia K, Hoffman R. Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells[J]. Blood, 1994;83: 1507-1514. [15] Collins MKL, Marvel J, Malde P, et al. Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents[J]. J ExpMed, 1992;176: 1043-1051. [16] Shah AJ, Smogorzewska EM, Hannum C, et al. Flt3 ligand induces proliferation of quiescent human bone marrow CD34+CD38- cells and maintains progenitor cells in vitro[J]. Blood, 1996;87: 3563-3570. [17] Borge OJ, Ramsfjell V, Cui L. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+ CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin[J]. Blood, 1997;90: 2282-2292. [18] Ritchie A, Saroj VR, Hal E. Broxmeyer. Thrombopoietin Suppresses Apoptosis and Behaves as a Survival Factor for the Human Growth Factor-Dependent Cell Line, MO7e[J]. Stem Cell, 1996;14: 330-336. [19] Osada M, Komeno T, Todokoro K, et al. Immature megakaryocytes undergo apoptosis in the absence of thrombopoietin[J]. Exp Hematol, 1999;27: 131-138. |